Home/Filings/4/0001725160-25-000028
4//SEC Filing

EASTLAND JULIA MARIE 4

Accession 0001725160-25-000028

CIK 0001725160other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:37 PM ET

Size

4.8 KB

Accession

0001725160-25-000028

Insider Transaction Report

Form 4
Period: 2025-01-31
EASTLAND JULIA MARIE
DirectorCEO & President
Transactions
  • Purchase

    Common Stock

    2025-01-31$1.73/sh+28,500$49,34528,500 total

Issuer

Zentalis Pharmaceuticals, Inc.

CIK 0001725160

Entity typeother

Related Parties

1
  • filerCIK 0001500189

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:37 PM ET
Size
4.8 KB